2013
DOI: 10.2147/ijn.s39534
|View full text |Cite
|
Sign up to set email alerts
|

The comparative immunotoxicity of mesoporous silica nanoparticles and colloidal silica nanoparticles in mice

Abstract: Background: Mesoporous silica (MPS) nanoparticles (NPs), which have a unique pore structure and extremely large surface area and pore volume, have received much attention because of their biomedical application potential. Using MPS NPs for biomedical devices requires the verification of their biocompatibility because the surface area of NPs is one of the most important determinants of toxicity, including the cellular uptake and immune response. We have previously reported that the cytotoxicity and inflammation… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
13
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 42 publications
(15 citation statements)
references
References 39 publications
2
13
0
Order By: Relevance
“…In contrast, mice that underwent prolonged IP administration of either AMPCol or AMP had comparable immunoglobulin levels to untreated animals. According to other studies 50 71 , these results suggest that AMPCol and AMP effect on immune system function on the parameters determined.…”
Section: Discussionsupporting
confidence: 72%
“…In contrast, mice that underwent prolonged IP administration of either AMPCol or AMP had comparable immunoglobulin levels to untreated animals. According to other studies 50 71 , these results suggest that AMPCol and AMP effect on immune system function on the parameters determined.…”
Section: Discussionsupporting
confidence: 72%
“…Elevated IgG/IgM levels were also observed in the MSN treated animals. The results indicate that MSNs showed a greater extent of damage than colloidal silica NPs [ 271 ]. However, a careful study of the toxicity is needed to establish the safety of MSNs.…”
Section: Biodistribution and Biocompatibility Of Msnsmentioning
confidence: 99%
“…Conventional MSNs can load a dose of therapeutic drug with 200-300 mg (maximally about 600 mg) drug/1 g silica. For example, conventional glucose-responsive insulin delivery systems suffer from the decrease of insulin release with repeated cycles[ 18 51 ] [ Table 3 ].…”
Section: Applications Of Mesoporous Silica Nanoparticlesmentioning
confidence: 99%